SavedAdd your journal

Journals / Haseki Tıp Bülteni / 2015 / Cilt: 53 - Sayı: 2

The Use of Haemodiafltration in conditions other than renal insuffciency

Böbrek yetmezliği dışında Hemodiafltrasyon kullanımı

SEÇİL CONKAR
İPEK KAPLAN BULUT
Sevgi MİR
Pages
110–115
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Adequate dialysis and close follow up of patients are thought to be more important than the mode of dialysis. (The Me di cal Bul le tin of Ha se ki 2015; 53: 110-15)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Continuous renal replacement therapy (CRRT) has recently become an important treatment modality in patients with acute renal failure in intensive care units.
📊
Key Findings & Data:CRRT is also administered in non- renal patients with conditions of undetermined causes.
💡
Conclusion & Impact:Adequate dialysis and close follow up of patients are thought to be more important than the mode of dialysis. (The Me di cal Bul le tin of Ha se ki 2015; 53: 110-15)
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Continuous renal replacement therapy (CRRT) has recently become an important treatment modality in patients with acute renal failure in intensive care units. CRRT is also administered in non- renal patients with conditions of undetermined causes. While removal of infammatory cytokines is aimed in diseases such as systemic infammatory response syndrome, sepsis and acute respiratory distress syndrome, the therapy is used to remove endogenous toxic solutes in conditions such as congenital metabolic disorders, crush syndrome, lactic acidosis, and tumor lysis syndrome. Although hemodiafltration is being increasingly used, in clinical trials, its effcacy has not been fully established yet. Excessive dialysis confers no additional benefts to patients. Adequate dialysis and close follow up of patients are thought to be more important than the mode of dialysis. (The Me di cal Bul le tin of Ha se ki 2015; 53: 110-15)

Özet

Sürekli renal replasman tedavisi (SRRT) son zamanlarda akut böbrek yetmezlikli yoğun bakım hastalarında önemli tedavi yöntemi haline gelmiştir. SRRT ayrıca nedeni belirlenemeyen böbrek dışı hastalıklarda da uygulanmaktadır. Sistemik yangısal yanıt sendromu, sepsis, akut sıkıntılı solunum sendromu gibi hastalıklarda infamatuvar sitokinlerin temizlenmesi amaçlanırken, doğuştan metabolizma bozuklukları, ezilme sendromu, laktik asidoz ve tümör lizis sendromu gibi tablolarda kullanım nedeni endojen toksik solütlerin temizlenmesidir. Hemodiyofltrayonun son zamanlarda giderek artan kullanımı olmasına rağmen klinik çalışmalarda henüz etkinliği tam olarak gösterilmemiştir. Aşırı diyalizin faydalı etkisi yoktur. Sonuçta hastanın uygun diyaliz tedavisi için tedaviyi uygulayan doktorun, diyaliz hemşiresinin ilgisi, takibi diyaliz tipinden daha etkili olduğu düşünülmektedir. (Ha se ki Tıp Bül te ni 2015; 53: 110-15)

🔖

Cite This Article

CONKAR, S., BULUT, İ. K., MİR, S. (2015). The Use of Haemodiafltration in conditions other than renal insuffciency. Haseki Tıp Bülteni, Cilt: 53 - Sayı: 2, 110–115. https://ajindex.com/articles/213509

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Schetz MR. Classical and alternative indications for continuous renal replacement therapy. Kidney Int suppl 1998;66:129-32
  2. Schetz M. Non-renal indications for continuous renal replacement therapy. Kidney Int Suppl 1999;56:88-94
  3. Boon We Teo, Jennifer S Messer, Emil P Paganini, John T Daugirsdas, Todd S. Ing.Diyaliz el kitabı. In: Bozfakıoğlu S, editör. Yavaş sürekli tedaviler. 4th ed. 2010. p. 219-63
  4. Schetz M, Ferdinande P, Vab Den Berghe G, Verwaest C, Lauwers P. Removal of pro-infammatory cytokines with renal replacement therapy: Sense or nonsense? Intensive Care Med 1995;21:169-76
  5. Gotloib L, Barzilay E, Shustak A, Wais Z, jaichenko J, Mev A. Hemofltration in septic ARDS: The artifcial kidney as an artifcial endocrine lung. Resuscitation 1986;13:123-32
  6. Van Bommel EF, Hesse CJ, Jutte NH, Zietse R, Bruining HA, Weirmar W. Impact of continuous hemofltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic infammatory response syndrome. Ren Fail 1997;19:443-54
  7. Barrera P, Janssen EM, Demacker PN, Wetzels JF, Van Der Meer JW. Removal of interleukin-1 beta and tumor necrosis factor from human plasma by in vitro dialysis with polyacrylonitrile membranes. Lymphokine Cytokine Res 1992;11:99-104
  8. Kellum JA, Johnson JP, Kramer D, Palevsky P, Brady JJ, Pinsky MR. Diffusive versus convective therapy. Effects on mediators of infammation in patient with severe systemic infammatory response syndrome. Crit Care Med 1998;26:1995-2000
  9. Lonneman G, Linnenweber S, Burg M, Koch KM. Transfer of endogenous pyrogens across artifcial membranes? Kidney Int suppl 1998;66:43-6
  10. De Vriese AS, Colardyn FA, Philippé JJ, Vanholder RC, De Sutter JH, Lameire NH. Cytokine removal during continuous hemofltration in septic patients. J Am Soc Nephrol 1999;10:846-53
  11. Grootendorst AF, van Bommel EF, van Leengoed LA, Nabuurs M, Bouman CS, Groeneveld AB. High volume hemofltration improves hemodynamics and survival of pigs exposed to gut ischemia and reperfusion. Shock 1994;2:72-8
  12. Braun N, Rosenfeld S, Giolai M, et al. Effect of continuous hemodiafltration on IL-6, TNF-α, C3a, and TCC in patients with SIRS/septic shoch using two different membranes. Contrib Nephrol 1995;116:89-98
  13. Wakabayashi Y, Kamijou Y, Soma K,Ohwada T. Removal of circulating cytokines by continuous hemofltration in patients with systemic infammatory response syndrome or multiple organ dysfunction syndrome. Br J Surg1996;83:393-4
  14. Bone RC. Sir